Medicinal Genomics
Yvonne Helbert is a seasoned scientist with extensive experience in the field of genomics and biochemistry. Currently serving as a Sr. Scientist at Medicinal Genomics since July 2017, Yvonne previously held positions at Courtagen Life Sciences, Inc./Medicinal Genomics as a Scientist from March 2011 to July 2017, and at Beckman Coulter as a Sr. Scientist from June 2005 to March 2011. Earlier in Yvonne's career, a role as a Research Associate at US Genomics was undertaken from 2004 to 2005. Yvonne Helbert earned a Master's degree in Biochemistry from Boston University School of Medicine (2002-2004) and a Bachelor's degree in Biology from Syracuse University (1997-2001).
This person is not in the org chart
This person is not in any offices
Medicinal Genomics
Medicinal Genomics is pioneering the genomics of medical cannabis and hemp. In 2011, Medicinal Genomics made worldwide headlines for being the first group to decode the Cannabis Genome. An increasing amount of scientific evidence supports the theory that cannabinoid compounds may have numerous medical benefits. Medicinal Genomics has the largestDNA sequence database of the cannabis plant and is well-positioned to design fingerprinting assays for strain genotyping and sequencing services for strain development. In 2011, Medicinal Genomics was acquired by Courtagen Life Sciences, Inc.